These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18166795)

  • 41. [Mastocytosis: when should it be considered?].
    Comte-Perret S; Bart PA; Spertini F; Leimgruber A
    Rev Med Suisse; 2009 Apr; 5(199):837-42. PubMed ID: 19441750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Indolent systemic mastocytosis.
    Vano-Galvan S; De la Hoz B; Nuñez R; Jaen P
    Isr Med Assoc J; 2010 Mar; 12(3):185-7. PubMed ID: 20684189
    [No Abstract]   [Full Text] [Related]  

  • 43. Systemic mastocytosis: current concepts and treatment advances.
    Tefferi A; Pardanani A
    Curr Hematol Rep; 2004 May; 3(3):197-202. PubMed ID: 15087068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-13 promoter gene polymorphism -1112C/T is associated with the systemic form of mastocytosis.
    Nedoszytko B; Niedoszytko M; Lange M; van Doormaal J; Gleń J; Zabłotna M; Renke J; Vales A; Buljubasic F; Jassem E; Roszkiewicz J; Valent P
    Allergy; 2009 Feb; 64(2):287-94. PubMed ID: 19178408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical aspects of paediatric mastocytosis: a review of 101 cases.
    Lange M; Niedoszytko M; Renke J; Gleń J; Nedoszytko B
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):97-102. PubMed ID: 22126331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis.
    Quintás-Cardama A; Sever M; Cortes J; Kantarjian H; Verstovsek S
    Leuk Lymphoma; 2013 Sep; 54(9):1959-64. PubMed ID: 23278641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells.
    Akin C; Jaffe ES; Raffeld M; Kirshenbaum AS; Daley T; Noel P; Metcalfe DD
    Am J Clin Pathol; 2002 Aug; 118(2):242-7. PubMed ID: 12162685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic mastocytosis in association with chronic lymphocytic leukemia: a rare diagnosis.
    Ault P; Lynn A; Tam CS; Medeiros LJ; Keating MJ
    Leuk Res; 2007 Dec; 31(12):1755-8. PubMed ID: 17521719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre.
    Hermans MAW; Rietveld MJA; van Laar JAM; Dalm VASH; Verburg M; Pasmans SGMA; Gerth van Wijk R; van Hagen PM; van Daele PLA
    Eur J Intern Med; 2016 May; 30():25-30. PubMed ID: 26809706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mastocytosis and anaesthesia].
    Dewachter P; Mouton-Faivre C; Cazalaà JB; Carli P; Lortholary O; Hermine O
    Ann Fr Anesth Reanim; 2009 Jan; 28(1):61-73. PubMed ID: 19097849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pre-inpatient evaluation on quality and impact of care in systemic mastocytosis and the influence of hospital stay periods from the perspective of patients: a pilot study.
    Nowak A; Gibbs BF; Amon U
    J Dtsch Dermatol Ges; 2011 Jul; 9(7):525-32. PubMed ID: 21992665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
    Brockow K; Jofer C; Behrendt H; Ring J
    Allergy; 2008 Feb; 63(2):226-32. PubMed ID: 18186813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hypereosinophilia as the leading symptom in a patient with mastocytosis].
    Musch E; Parwaresch R; Malek M; Chrissafidou A
    Med Klin (Munich); 2005 May; 100(5):286-7. PubMed ID: 15902384
    [No Abstract]   [Full Text] [Related]  

  • 54. Undiagnosed systemic mastocytosis in a teenager revealed during general anesthesia.
    Goldfinger MM; Sandadi J
    Paediatr Anaesth; 2010 Mar; 20(3):290-1. PubMed ID: 20470330
    [No Abstract]   [Full Text] [Related]  

  • 55. Mast Cell Burden in a Patient With Cutaneous Disease.
    Awosika O; Eleryan M; Rengifo-Pardo M; Ehrlich A
    J Drugs Dermatol; 2017 Dec; 16(12):1285-1287. PubMed ID: 29240865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mastocytosis of the female breast.
    Setia N; Crisi GM; Pantanowitz L
    Int J Surg Pathol; 2010 Oct; 18(5):374-8. PubMed ID: 19223379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can Diagnostic Low-dose Whole-body CT Reflect Bone Marrow Findings in Systemic Mastocytosis?
    Meyer HJ; Pönisch W; Monecke A; Gundermann P; Surov A
    Anticancer Res; 2020 Feb; 40(2):1015-1022. PubMed ID: 32014947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients.
    Benner MF; Willemze R
    Br J Dermatol; 2008 Nov; 159(5):1148-51. PubMed ID: 18782320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites.
    Keyzer JJ; de Monchy JG; van Doormaal JJ; van Voorst Vader PC
    N Engl J Med; 1983 Dec; 309(26):1603-5. PubMed ID: 6646186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Systemic mastocytosis].
    Fain O; Stirnemann J; Lortholary O
    Rev Prat; 2005 Oct; 55(15):1629-36. PubMed ID: 16334197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.